Latest 10-K annual reports

Scientist Home Future Health Limited reported a significant net loss and net current liabilities for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern, despite revenue growth and expansion plans.

Epsilon Energy reports a net loss for 2025 despite significant revenue growth and a major acquisition, highlighting challenges in commodity pricing and asset divestitures.

Ideal Power's latest 10-K filing highlights ongoing B-TRAN commercialization, a recent $12.6 million capital raise, and a CEO transition amidst continued net losses.

Community Bancorp./VT reported a significant increase in net income and loan growth for fiscal year 2025, alongside its common stock listing on the Nasdaq Capital Market.

United-Guardian, Inc. reported a 13% decrease in total sales for 2025, driven by a significant decline in cosmetic ingredient sales, while pharmaceutical and medical lubricant sales saw growth.

Non-Invasive Monitoring Systems Inc. (NIMS) filed its transition report, revealing continued operating losses and a proposed merger with Gravitics Inc. to pivot into the space structures industry.

Adagio Medical Holdings, Inc. reported recurring net losses and a going concern warning, despite advancing its vCLAS Cryoablation System with Breakthrough Device Designation and positive clinical trial results.

Hydrofarm Holdings Group, Inc. reported a substantial net loss of $289.8 million for fiscal year 2025, driven by significant impairment charges and declining sales, raising substantial doubt about its ability to continue as a going concern.

Senti Biosciences reported significant losses and expressed substantial doubt about its ability to continue as a going concern, despite positive Phase 1 clinical data for its lead CAR-NK cell therapy, SENTI-202.

Arrow Financial Corporation filed an amendment to its 2025 Annual Report on Form 10-K to include its previously omitted Clawback Policy.

SBC Medical Group Holdings Incorporated reported a 9.33% increase in net income for 2025, alongside strategic acquisitions and ongoing international expansion, despite a 15.48% decrease in total revenues.

HG Holdings, Inc. reported a significant increase in total revenues for 2025, driven by growth in management fees and title insurance premiums, leading to a return to net profitability despite an investment impairment.

Werewolf Therapeutics, Inc. announced a significant restructuring, including a 64% workforce reduction, and is exploring strategic alternatives to address substantial doubt about its ability to continue as a going concern.

Dolphin Entertainment significantly reduced its net loss in 2025 while growing revenue, despite increasing debt and ongoing internal control challenges.

Instil Bio, a biotechnology company, has discontinued its lead product candidate AXN-2510 and is now actively seeking to acquire new therapeutic candidates, facing ongoing significant losses and a going concern indicator.

Clear Channel Outdoor Holdings, Inc. filed an amendment to its 2025 Annual Report to include detailed information on executive compensation, corporate governance, and director independence.

American Bitcoin Corp. reports significant Bitcoin reserve growth and improved mining efficiency for fiscal year 2025, following strategic mergers and capital raises.

Luminar Technologies, a LiDAR technology company, has filed for Chapter 11 bankruptcy, sold substantially all of its assets, and is proceeding with a plan of liquidation.

Wen Acquisition Corp.'s 2025 10-K details its ongoing search for a fintech business combination, highlighting strong trust account growth but also significant operational risks and a going concern warning.

Globa Terra Acquisition Corporation, a blank check company, filed its annual report detailing its financial position, search strategy for a business combination in agribusiness and water sectors, and the risks associated with its SPAC structure.

Churchill Capital Corp XI, a blank check company, filed its annual 10-K report, outlining its initial public offering, search for a business combination, and financial position as of December 31, 2025.

Proem Acquisition Corp. I, a blank check company, completed its Initial Public Offering and private placement in February 2026, raising $130 million for its trust account, and outlined its strategy to acquire a high-growth technology-driven enterprise.

Nu Ride Inc. reports a significantly reduced net loss for 2025, focusing on litigation against Foxconn and new billboard loan investments post-bankruptcy.

Southland Holdings, Inc. reported a significant net loss of $308.4 million for 2025, driven by an adverse legal ruling and declining revenue and backlog.

SpyGlass Pharma, Inc. reports significant progress in its BIM-IOL System for glaucoma, initiating two Phase 3 clinical trials and completing a successful IPO in early 2026, despite ongoing financial losses.

GP-Act III Acquisition Corp., a blank check company, filed its 2025 Annual Report on Form 10-K, detailing its financial position, ongoing search for a business combination, and associated risks.

Seafarer Exploration Corp. reports significant operating losses, a substantial working capital deficit, and auditor doubts about its ability to continue as a going concern for the year ended December 31, 2025.

DBV Technologies reports positive Phase 3 VITESSE results for its Viaskin Peanut patch in children aged 4-7, secures significant financing, and outlines accelerated regulatory pathways for both toddler and child populations in the U.S.

Abercrombie & Fitch Co. reported a 6% increase in net sales for Fiscal 2025, reaching $5.27 billion, but saw a decline in operating income and net income compared to the prior year, alongside a strategic review of its APAC business.

Dermata Therapeutics shifts focus from prescription drugs to direct-to-consumer and B2B skincare products, reporting continued losses and a going concern warning.